Top Markets
#1 Siacoin Siacoin +52.09%
#2 Official Trump Official Trump +35.11%
#3 Melania Meme Melania Meme +22.79%
#4 Nockchain Nockchain +21.64%
#5 EXOD EXOD +18.93%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +18.88%
#7 MowCat MowCat +18.80%
#8 Mubarak Mubarak +17.99%
#9 Unit Pump Unit Pump +15.74%
#10 Pump.fun Pump.fun +15.74%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Rank in Stocks #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Share Price
$19.30
Last synced: 2023-12-26
Market Cap
$72.77M
Change (1 day)
6.22%
Change (1 year)
0.00%
Country
US
Trade Aeglea BioTherapeutics, Inc. (AGLE)

Category

Healthcare
Earnings for Aeglea BioTherapeutics, Inc. (AGLE)
Earnings in 2026 TTM: 0
According to Aeglea BioTherapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Aeglea BioTherapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH